Bronchiectasis

Questions discussed in this category

Do you integrate inhaled colistimethate sodium into existing treatment regimens for patients with bronchiectasis and PSAR infection?

PROMIS-I and II

2 Answers available

Do you utilize the bronchiectasis severity index (BSI) in your approach to managing non-CF bronchiectasis?

1 Answer available

How might the introduction of brensocatib as a treatment option impact the use of other anti- inflammatory or antibiotic therapies currently employed in bronchiectasis management?

1 Answer available

How do you manage persistent pseudomonas positive sputum a patient with non-CF bronchiectasis who has chronic sputum production but is otherwise asymptomatic?

2 Answers available

Do you treat non-albicans strains of Candida on sputum culture or BAL in patients who are immunosuppressed?

2 Answers available

What is your approach to initial work up for a young patient with bronchiectasis?

2 Answers available

Are you using NAC in lieu of hypertonic saline amidst the current shortage of hypertonic saline in patients with either CF or non-CF bronchiectasis?

1 Answer available

Do you ever stop tobramycin prophylaxis in a patient with chronic bronchiectasis previously colonized with pseudomonas?

2 Answers available

Papers discussed in this category

American journal of respiratory and critical care medicine, 2013-04-01

Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health.

Eur Respir J, 2017 Sep 09

European Respiratory Society guidelines for the management of adult bronchiectasis.

Thorax, 2019 Jan

British Thoracic Society Guideline for bronchiectasis in adults.

The New England journal of medicine, 2025 Apr 24

Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis.

JAMA, 2013 Mar 27

Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial.

Related Topics